Our previous studies suggested that chromosome 8p deletion is associated with metastasis of hepatocellular carcinoma (HCC), in which some novel metastasis suppressor genes might be harbored. The present study aimed to identify the metastatic suppressor gene(s). A cDNA chip was constructed with the expressed sequence tags (ESTs) from chromosome 8p and used to compare the difference of expression profiling between the MHCC97-H and MHCC97-L cell lines with different metastatic potentials and similar genetic backgrounds. In all, 10 ESTs were significantly downregulated in MHCC97-H cell line with higher metastatic potential. One full-length gene, HTPAP (phosphatidic acid phosphatase type 2 domain containing 1B), was identified at chromosome 8p12. Sequencing and bioinformatic analyses revealed that HTPAP has 826 bp and encodes a putative protein of 175 amino acids with a transmembrane segment at the NH2 terminus, two protein kinase C phosphorylation site and one tyrosine kinase phosphorylation site. Its expression level in metastatic tumor tissues was much lower than that of primary HCC tissues. Both in vitro and in vivo assays suggested that HTPAP could suppress the invasion and metastasis of HCC. These suggested that HTPAP is a novel metastatic suppressor gene for HCC. The mechanism of the effect of HTPAP on HCC metastasis is not clear yet and deserves further investigation.
Introduction
Human hepatocellular carcinoma (HCC) is a common and aggressive malignance with especially high prevalence in Asia and Africa (Tang, 2000; Wang et al., 2001b) . It is the third most frequent killer among cancer deaths in men and seventh most frequent in women because of its very dismal prognosis (Hussain et al., 2001) . So far, curative resection remains the major therapeutic method for HCC. However, only a definitive subset of patients have any chance of being cured, because of the great possibility of intrahepatic tumor recurrence after surgical operation. Metastasis is one of the major causes of tumor recurrence. Therefore, exploring the molecular mechanisms involved in the process of HCC metastasis is the key issue for the study of HCC, which could be helpful in the prediction and early diagnosis of HCC recurrence and could also provide new therapeutic targets for HCC metastasis, both of which would be helpful in further improving the long-term survival of patients with HCC (Tang, 2001) .
HCC metastasis is a multistep process that involves multiple genes (Liotta et al., 1991; Tang et al., 2004) . During the past few years, many efforts have been paid to explore the mechanisms involved in the metastasis of HCC, and some metastasis-and invasion-related factors have been identified. In our recent studies, we found that chromosome 8p deletion might contribute to HCC metastasis (Qin et al., 1999) . This result was further confirmed by comparisons in nude mice models of HCC with different metastatic potentials (Qin et al., 2001) . In addition, a more accurate location was identified on 8p23.3 and 8p11.2 (Zhang et al., 2003) . These findings provide new locus for exploring a new candidate metastasis suppressor of HCC. On the basis of these previous findings, in this study, we aimed to identify the candidate metastatic suppressor gene on chromosome 8p and to analyse its potential functions on the metastasis of HCC.
Results

Identification of the HTPAP gene
In cDNA microarray assays, compared with the MHCC97-L (lower metastatic potential HCC cell line), 10 expressed-sequence tags (ESTs) were significantly downregulated in the MHCC97-H cell line (which is highly metastatic potential HCC cell line). These two human HCC cell line are established from the same parent human HCC cell line MHCC97. They have similar genetic background, but have different metastatic potential. One leading differently expressed EST (GenBank accession No. R41762) was selected as the candidate sequence for further study. This EST is located at 8p12, which has been suggested to be one of the most possible regions to harbor a metastasis suppressor gene according to the results of our previous molecular cytogenetic studies (Zhang et al., 2003) . On the basis of the bio-information analysis, this EST was thought to be the cDNA fragment of the HTPAP gene (GenBank accession No. AF212238). Therefore, this gene was amplified and cloned by reverse-transcription-polymerase chain reaction (RT-PCR) and was revealed to have 826 bp that encoded a putative protein of 175 amino acids by sequence analysis (Figures  1 and 2 ). SMART software (Letunic et al., 2004) analysis showed that this protein has a transmembrane segment at the NH2 terminus (aa 20-37), an acid phosphatase homologue that occupies most of the protein (aa 48-173), with three potential phosphorylation sites, including two protein kinase C (PKC) phosphorylation sites and one tyrosine kinase phosphorylation site.
Downregulated expression of HTPAP in metastatic HCC tissues and cell lines
Serial HCC cell lines of MHCC97-L, MHCC97-H, and HCCLM3 were established from the same parent human HCC cell line, MHCC97 in the author's institute. They have an identical genetic background and stepwise increasing metastatic potentials (Li et al., 2004) . As shown in Figure 3a (real time PCR), the expression of HTPAP gene was downregulated in the highly metastatic potential cell line (MHCC97-H, and HCCLM3) compare with low metastatic potential HCC cell line(MHCC97-L). The expression level of HTPAP in MHCC97-H and HCCLM3 cell lines is only 11.8 and 7% of the HTPAP level in MHCC97-L cell line, respectively.
To clarify its association with HCC metastasis, HTPAP expression levels were examined in 16 samples of metastatic and their paired primary HCC tissues by quantitative real-time PCR. The HTPAP expression could be detected in all of the tumor tissues. In 11 of 16 cases (68.8%), the HTPAP expression was downregulated in metastatic tumor tissues compared to their corresponding primary tumor tissues, and a significant lower HTPAP level was found in nine metastatic lesions (56.3%) vs primary HCC. The difference is significant according to paired-samples t-test (Po0.05). In the other five cases, the HTPAP was overexpressed in primary HCC tissues (Figure 3b ).
Effect of HTPAP gene on the proliferation and invasion of HCC cells
To determine the role of HTPAP on HCC cell invasion, the recombinant adeno-associated virus (rAAV) particles containing the HTPAP gene were used for delivery into highly metastatic potential MHCC97-H cell line. Assayed by real time PCR, the expression level of HTPAP gene in MHCC97-H cell line is only 7.5% of the HTPAP level in MHCC97-L cells (Figure 3a) . The overexpression of HTPAP in the transfected cells was confirmed by RT-PCR. The in vitro proliferation ability of HCC cells was slightly inhibited by HTPAP transfection; however, this difference was not statistically significant (Figure 4 ).
An in vitro Matrigel invasion assay showed that, in the group of pAAV2-HTPAP transfected cells, the number of cells invaded through the transwell membrane (5.270.7) was significantly lower than that in the pAAV2 control group (10.373.5, Po0.05), whereas the number of cells infected through the transwell of the pAAV2-antiHTPAP transfected group was significantly higher than that of the pAAV2 control group (14.573.6 vs 10.373.5, Po0.05) ( Figure 5 ). This suggested that the HTPAP gene could inhibit invasion ability but had no significant effect on the proliferation of HCC cells. Identification of HCC metastatic suppressor HTPAP X Wu et al Inhibitory effect of the HTPAP gene on lung metastasis of HCC The transfection and expression of the HTPAP gene could significantly decrease both the incidence and degree of the pulmonary metastasis of nude mice bearing human HCC. HCC-LM3 cell line was used for in vivo assays, in which the HTPAP level was only 11.8% of the HTPAP level in MHCC97-L (Figure 3a) .
The median number of lung metastatic nodules in the HTPAP transfection group (0.6371.19/mouse) was also much lower than that of the pIRES2-EGFP vector mock control group (5.6372.25/mouse) and the PBS control group (4.8672.27/mouse) (Po0.05). The pulmonary metastatic rate of the nude mice in the HTPAP gene transfection group (25.5%) was much lower than that of group with pIRES2-EGFP vector mock control Table 1 ). However, the expression of the HTPAP gene had no obvious effect on the growth of the primary tumors, compared with the void vector control group (1.7570.35 vs 1.7470.24, P>0.05). These results suggested that the expression of HTPAP was able to significantly inhibit the lung metastasis of nude mice bearing human HCC but had no significant influence on the growth of HCC cells.
Discussion
Just as other solid malignant tumors, HCC metastasis is a complex process of interaction between the host and Identification of HCC metastatic suppressor HTPAP X Wu et al cancer cells, and this process is regulated by multiple genes. Understanding the genes responsible for either enhancing or suppressing this process would allow novel diagnostic, therapeutic, and prognostic applications in evolving and improving the clinical care of patients with HCC. It has been approved that more genetic aberrations exist during the process of cancer progression, invasion, and metastasis (Takeo et al., 2001; Tantivejkul et al., 2004) . These specific genomic aberrations could be used for mapping tumor suppressor genes (Thiagalin- In our previous studies, we found that HCC acquired a deletion on chromosome 8p during progression to the metastatic stage and chromosome 8p deletion might contribute to HCC metastasis (Qin et al., 1999) . This result was confirmed in a study of the metastatic model of HCC and its cell line (Qin et al., 2001) . Using genomewide microsatellite analysis, this deletion on chromosome 8p was further proved to be related to the progression and metastasis of HCC, and 8p23.3 and 8p11.2 were two likely regions harboring metastasisrelated genes (Zhang et al., 2003) . Similar results were obtained by other researchers (Li et al., 2001; Wang et al., 2001a) . Besides HCC, the deletion of chromosome 8p has also been shown to play an important role in the tumor progression and metastasis of many other kinds of human malignancies, including colorectal (Takanishi et al., 1997; Parada et al., 1999) , bladder (Wagner et al., 1997; Ohgaki et al., 1999; Muscheck et al., 2000) , breast (Yokota et al., 1999) , larynx (Kujawski et al., 1999) , renal (Bissig et al., 1999) , and lung (Petersen et al., 2000) cancers. Therefore, 8p might harbor one or more tumorsuppressor genes that are important in progression, especially the metastasis of cancers, including HCC (Nihei et al., 2002) . Several candidate tumor-suppressor genes have been identified from 8p, including DLC-1 (8p21.3-22) (Yuan et al., 1998) , FEZ1 (8p22) (Ishii et al., 1999) , liverrelated putative tumor suppressor gene (8p23) (Liao et al., 2000) , PCM1 (which encodes a centrosomal protein), and DUSP4/MKP-2 (which encodes a MAP kinase phosphatase) (Armes et al., 2004) . However, alterations in these genes may occur as an early event in the development of cancers, and their association with metastasis has not been confirmed (Park et al., 2002) , even though one very recent study indicated that FEZ1 may serve as a novel prognostic indicator for lung cancer (Nonaka et al., 2005) . It has been found that putative tumor-suppressor genes that are mapped on chromosomes 8p21-22 may be involved in the metastasis of colorectal cancer. Allelic losses in these regions are possible risk factors for early lymph node metastasis (Arai et al., 1998) . Using a functional positional cloning strategy, Nihei et al. (2002) defined the region harboring the metastasis suppressor gene in 8p21-12 and localized it to a 60-kb cloned region. To explore the new candidate metastatic suppressor of HCC, in this study, based on the finding of our previous works, we constructed a cDNA chip with ESTs from chromosome 8p and used it to compare the difference in geneexpression profiling between HCC cell lines with different metastatic potentials and similar genetic backgrounds. From the 10 leading downregulated ESTs in the MHCC97-H cell line with higher metastatic potential, the full-length of HTPAP gene was identified. This gene was aligned to chromosome 8p12, the most possible regions defined by allelic imbalance analyses by us (Zhang et al., 2003) and other researchers (Nihei et al., 2002) .
HTPAP is a novel gene, its official symbol is PPAPDC1B (Phosphatidic acid phosphatase type 2 domain containing 1B). This gene is conserved in Eukaryota, such as Homo sapiens, Pan troglodytes, Canis familiaris, Mus musculus, Rattus norvegicus, Arabinidosis thaliana, Oryzea sativa. It contains an acid phosphatase homologues domain. However, its function is not clear up to now. In this study, by the expression profiling analysis on the HCC cell lines, the HTPAP gene was identified as one of the leading genes downregulated in the high-metastatic-potential cell line, which suggests that the downregulation of the HTPAP gene might be associated with the metastatic potential of HCC. This association was clarified in the HTPAP expression levels in HCC tissues by quantitative realtime PCR. Therefore, we further investigated the potential functional role of HTPAP in the process of HCC metastasis. We found that the HTPAP gene could significantly inhibit the in vitro invasion ability and in vivo lung metastasis of HCC. These results provide more evidence that the HTPAP gene plays an important role in the process of HCC metastasis. However, no significant effect on the proliferation of the HCC cells was found, which suggests that HTPAP's suppression of HCC metastasis might be through other mechanisms, other than inhibiting the growth ability of cancer cells. Figure 7 The effect of HTPAP gene on the lung metastasis rate of hepatocellular carcinoma in nude mice bearing human HCC. The pulmonary metastatic rate of the nude mice in the HTPAP gene transfection group (25.5%) was much lower than that of group with pIRES2-EGFP vector mock control (87.5%) and of the PBS control group (85.7%). Po0.05 (one-way ANOVA analysis).
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Many metastatic suppressors, such as KAI1, CD44, mitogen-activated protein kinase (MAPK) 4, nm23-H1, nm23-H2, KiSS1, and BrMS1, have also been shown no significant effect on the primary tumor growth (Bogenrieder and Herlyn, 2003; Kauffman et al., 2003) . Among these, MAPK4 and KiSS1 probably suppress metastasis by inhibiting cancer cell growth at secondary sites. An important finding about cancer metastasis is that cancer cells subjected to growth regulation at the secondary site and to a specific protein, encoded by a metastasis suppressor gene, suppresses the metastatic phenotype. Recent studies have shown that certain metastasis suppressor proteins involved in such signal transduction cascades mediate cellular responses to growth factors, cytokines, and cellular stresses (Berger et al., 2004; Keller et al., 2004) . Our functional analysis also suggested that, as a metastasis suppressor gene, HTPAP may not be pivotal, but it might interact with some 'driver' metastatic suppresser genes to exert its function. These findings are partially supported by the observation that HTPAP expression was not sharply decreased in metastases of patients with liver cancer.
In summary, the HTPAP gene, which is located on chromosome 8p12, is downregulated in a metastatic HCC cell line as well as in HCC tissues. Functional analyses both in vitro and in vivo have suggested that it might play some role as a metastatic suppressor gene for HCC. However, the mechanism of HTPAP inhibiting HCC metastasis was not clear, and it deserves further investigation.
Materials and methods
Human HCC specimens and cell lines and RNA preparation Human HCC tissues and the paired surrounding noncancerous liver tissues were obtained from patients who underwent liver resection for HCC at the Liver Cancer Institute of Fudan University (Shanghai, China). All specimens were frozen in liquid nitrogen immediately after resection and were stored at À801C until use. All of the tumor tissues were from male patients who had a history of hepatitis B virus (HBV) infection. The diagnosis and histopathological features were confirmed to be HCC by pathologists.
Serial cell lines of MHCC97-L, MHCC97-H, and HCCLM3 were established from the same parent human HCC cell line, MHCC97, in the author's institute. They have an identical genetic background and stepwise increasing metastatic potentials (Li et al., 2004) . Cell lines were cultured in Dulbecco's modified Eagle's medium (DMEM) (Gibco BRL, NY, USA) supplemented with 10% (v/v) fetal calf serum (Hyclone, Utah, USA) at 371C in a humidified incubator that contained 5% CO 2 . Normal human liver cell L02 was used as control.
Total RNA was extracted from the HCC tissues and cell lines using TRIzol Reagent (Invitrogen, Carlsbad, CA, USA), according to the manufacturer's specifications. Total RNA was quantitated by spectrophotometry and then examined by 1% RNA agarose gel electrophoresis to confirm its quality. Poly(A) þ mRNA was obtained from the total RNA of the cell lines for cDNA chip hybridization.
Construction of small cDNA chips and cDNA microarray assays On the basis of search results from the UniGene clusters in GenBank (http://www.ncbi.nlm.nih.gov/UniGene/) and the Unified Database (http://bioinformatics.weizmann.ac.il/udb/, version of November 2001), 100 ESTs on human chromosome 8p were selected for the construction of cDNA chips. All of these 100 EST clones were obtained from Invitrogen (Research Genetics, Huntsville, AL, USA).
Next, 1-2 mg of poly(A) þ mRNA were labeled in an RT reaction in the presence of 200 Ci [a-33 P] deoxyadenosine 5 0 -triphosphate (DuPont NEN, Boston, MA) using Moloney murine leukemia virus RT (Promega Corp., Madison, WI, USA). The hybridization was performed as previously described (Xu et al., 2001) . Hierarchical clustering was analysed using CLUSTER and TREEVIEW software with median-centered correlation and complete linkage (Eisen et al., 1998) .
Identifying of the differently expressed ESTs and cloning of HTPAP gene Compared with the MHCC97-L (which has lower metastatic potential), 10 ESTs were significantly downregulated in the MHCC97-H cell line (which has higher metastatic potential). One of the leading differently expressed ESTs was selected, and its sequence was used to align by blast search (www.ncbi.nlm.nih.gov/blast/) against the NCBI human nucleotide databases. This EST was found to be highly homologous to the HTPAP gene. Using the primers of this gene (GeneBank accession number NP_115872) (forward, 5 0 -GAGACTCATCCAGCCGGAGGAG-3 0 ; reverse 5 0 -ATGCA AAGGAAGAATGTCCACT-3 0 ) and b-actin (forward, 5 0 -CCTCGCCTTTGCCGATCC-3 0 , reverse 5 0 -GGATCTTCA TGAGGTAGTCAGTC-3 0 ), semiquantitative RT-PCR was used to validate its expression the cell lines with different metastatic potential.
Detection of HTPAP gene expression in HCC tissues
Using DNA Engine Opticon system, Opticon Monitor software (version 1.02; MJ Research Inc., Reno, NV, USA) and the QuantiTectTM SYBR s Green RT-PCR kit (Qiagen), realtime quantitative RT-PCR analyses were performed to identify the express level of the HTPAP gene in HCC tissues and surrounding noncancerous liver tissues. Total RNA of the HCC tissues was digested with amplification grade DNaseI (Invitrogen) before cDNA synthesis. b-actin mRNA was detected at the same time, to serve as the internal control. Regular RT-PCR was performed before real-time PCR to determine the amplification condition to have specific amplification. Using the specific primers for amplification of HTPAP (forward, 5 0 -CTGGCTCTGAATGGCGTCTTTA CC-3 0 ; reverse, 5 0 -GCCCTCATTCACCACGTCCTTATC-3 0 ) and b-actin (forward, 5 0 -TCACCCACACTGTGCCCATCT ACGA-3 0 ; reverse, 5 0 -CAGCGGAACCGCTCATTGCCAA TGG-3 0 ), reverse transcription was performed at 501C for 30 min, and activation was done with HotStar Taq DNA Polymerase at 951C for 15 min, followed by 45 cycles of 941C for 15 s, 561C for 30 s, and 721C for 30 s. The pIRES2-EGFP vectors containing HTPAP and b-actin were used as the templates to generate the standard curves. The data were analysed by Opticon Monitor software.
Construction of the recombinant plasmid of HTPAP gene Full-length cDNA sequence of the HTPAP was inserted into the BamHI and HindIII sites of pAAV-MCS (Stratagene, Cedar Creek, TX). This recombinant plasmid was called pAAV2-HTPAP. The antisense sequence of the HTPAP gene was inserted into pAAV-MCS in a reverse orientation and was called pAAV2-antisense HTPAP. The primers used for plasmid construction are listed in Table 2 . The sequences of Identification of HCC metastatic suppressor HTPAP X Wu et al the recombinants were confirmed by DNA sequencing. The recombinant vectors were cotransfected in HEK293 cell with pHelper and pAAV-RC, which together supply all of the transacting factors required for AAV replication and packaging in HEK293 cells. Then the AAV2 particles were harvested and used to infect MHCC97-H cells for in vitro assay.
Analysis of proliferation of HCC cells in vitro after HTPAP transfection
AAVs are replication-deficient parvoviruses, which have traditionally required coinfection with a helper adenovirus or herpesvirus for productive infection. We used Stratagene's AAV Helper-Free System, which allows the production of infectious human rAAV2 virions without the use of a helper virus and use three plasmids for cotransfection. Using Stratagene's in situ galactosidase staining kit to detect the viral titer, we got 10 6 viral particles per milliliter in primary stock. The pAAV2-HTPAP and pAAV2-antisense HTPAP virus particles were used to infect MHCC97-H cells at 10 5 MOI. After 5 days, the infected cells were used for in vitro functional assays. The transfected cells were seeded in 96-well culture plates at a density of 5 Â 10 3 cells per well, and cell numbers were measured by a MTT assay (Promega, Madison, WI) every day.
In vitro Matrigel assay on the invasion of HCC cells In vitro invasion assay were performed as described previously (Giannelli et al., 2002) , with some modifications. Briefly, 100 ml of serum-free DMEM-diluted Matrigel (0.8 mg/ml) (BD Biosciences, San Jose, California, USA) was added to the Transwell filters (8.0-mm pore size; Corning, NY) of a Boyden chamber and incubated at 371C for 2 h to form matrix gels.
Then, 1 Â 10 5 MHCC97-H cells that were infected by pAAV2-HTPAP or pAAV2-antisenseHTPAP particles for 5 days were suspended in 100 ml of serum-free DMEM and then added to the top of the Matrigel in triplicate chambers; a mixture of 200 ml of DMEM with 10% fetal calf serum, 200 ml of supernatant of MHCC97-H cell culture, and 200 ml of supernatant of NIH/3T3 cell culture was added to the lower chamber to serve as the chemoattractant. After incubation at 371C for 48 h, the upper surface of the filters was wiped carefully with a cotton-tipped applicator, and the filters were fixed with 4% paraformaldehyde in PBS and stained with Giemsa stain. Cells invaded across the Matrigel and passed through the transwell filter pores toward the lower surface of the filters were counted in eight nonoverlapping Â 200 fields under a light microscope.
In vivo analysis of HTPAP transfection on HCC growth and metastasis To further evaluate the effect of HTPAP on HCC metastasis, an in vivo study was performed in a metastatic nude mice model bearing human HCC that was established in our institute. The full-length cDNA of the HTPAP gene was amplified and cloned into pIRES2-EGFP expression vector (Table 2) 7 cells in 0.2 ml of culture medium were injected subcutaneously into the right flank of nude mice. After 35 days, the mice were killed and autopsied. Whole lung consecutive section was used for the examination of the lung metastasis. Take first one of the every five consecutive sections for hematoxylin-eosin staining and examination for the lung metastasis. The thickness of each section is 8 mm and total number of slides is about 100 per mouse. 
